United States - English - NLM (National Library of Medicine)

wockhardt limited - captopril (unii: 9g64rsx1xd) (captopril - unii:9g64rsx1xd) - captopril 12.5 mg - hypertension: captopril tablets, usp are indicated for the treatment of hypertension. in using captopril, consideration should be given to the risk of neutropenia/agranulocytosis (see warnings ). captopril may be used as initial therapy for patients with normal renal function, in whom the risk is relatively low. in patients with impaired renal function, particularly those with collagen vascular disease, captopril should be reserved for hypertensives who have either developed unacceptable side effects on other drugs, or have failed to respond satisfactorily to drug combinations. captopril is effective alone and in combination with other antihypertensive agents, especially thiazide-type diuretics. the blood pressure lowering effects of captopril and thiazides are approximately additive. heart failure: captopril tablets are indicated in the treatment of congestive heart failure usually in combination with diuretics and digitalis. the beneficial effect of captopril in heart failure does not require the presence

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - captopril, quantity: 12.5 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; magnesium stearate; croscarmellose sodium; colloidal anhydrous silica; lactose monohydrate - hypertension: captopril is indicated for the treatment of hypertension consideration should be given to the risk of neutropenia/ agranulocytosis when using captopril (see precautions). captopril is effective alone and in combination with other antihypertensive agents, especially thiazide-type diuretics. the blood pressure lowering effects of captopril and thiazides are approximately additive. myocardial infarction - captopril is indicated to improve survival following myocardial infarction in clinically stable patients with left ventricular dysfunction, manifested as an ejection fraction less than or equal to 40% and to reduce the incidence of overt heart failure, and subsequent hospitalisation for congestive heart failure in these patients. the efficacy data for the use of captopril following myocardial infarction are strongest for initiation of therapy beyond 3 days post-infarct. heart failure - captopril is indicated for the treatment of heart failure. in symptomatic patients it is recommended that captopril be administered together with a diuretic. diabetic nephropathy - captopril is indicated for the treatment of diabetic nephropathy (proteinuria > 500mg/day) in patients with type 1 insulin-dependent diabetes mellitus. in these patients captopril reduces the progression of renal disease and reduces associated clinical sequelae (dialysis, renal transplantation and death).

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

medihealth (northern) ltd - captopril - oral tablet - 12.5mg

Ireland - English - HPRA (Health Products Regulatory Authority)

rowex ltd - captopril - tablet - 12.5 milligram(s) - ace inhibitors, plain; captopril

Canada - English - Health Canada

pharmascience inc - captopril - tablet - 25mg - captopril 25mg - angiotensin-converting enzyme inhibitors

Ireland - English - HPRA (Health Products Regulatory Authority)

rowex ltd - captopril; hydrochlorothiazide - tablet - 25/12.5 mg milligram(s) - ace inhibitors and diuretics; captopril and diuretics

Canada - English - Health Canada

sorres pharma inc - captopril - tablet - 12.5mg - captopril 12.5mg - angiotensin-converting enzyme inhibitors

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - captopril 12.5mg;   - tablet - 12.5 mg - active: captopril 12.5mg   excipient: colloidal silicon dioxide croscarmellose sodium lactose monohydrate microcrystalline cellulose stearic acid

United States - English - NLM (National Library of Medicine)

golden state medical supply, inc. - captopril (unii: 9g64rsx1xd) (captopril - unii:9g64rsx1xd) - captopril 12.5 mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - captopril - oral tablet - 5mg